Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small lump under the skin after a Mounjaro injection is common and, in most cases, completely harmless. It usually forms because the tirzepatide solution has pooled briefly in the subcutaneous tissue before dispersing; the lump tends to flatten over a few hours to a couple of days. That said, knowing which kind of lump you're looking at (and what to watch for) is the real decision here. The injection technique you use and where you inject both play a bigger role than most people realise. Mounjaro is a prescription-only medicine; any persistent or concerning reaction should be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When you press the KwikPen against your skin and release the dose, a small volume of liquid enters the fatty layer beneath the surface. If the injection is slightly shallow, delivered too quickly, or the tissue is pressed too firmly during injection, the solution can sit in a pocket rather than dispersing straight away. The result is a visible or palpable bump (sometimes called a wheal) that feels firm and may look slightly raised or pale.
This is not the medicine doing anything unusual. It is simply the mechanics of subcutaneous delivery. The same thing can happen with any self-injected medicine, from insulin to low-molecular-weight heparin. As the tissue absorbs the solution, the lump fades. Most people find it has gone by the next morning; some notice it lingers for a day or two, particularly after a dose increase when the volume feels more noticeable.
Needle angle matters too. A 90-degree approach works for most adults with a reasonable amount of subcutaneous tissue; leaner individuals sometimes find a 45-degree angle avoids hitting the muscle beneath. The Mounjaro formulation itself contains inactive ingredients alongside tirzepatide, and these excipients are generally well tolerated — but they still need time to be absorbed by surrounding tissue.
One thing our prescribers hear fairly often: people assume the lump means the dose didn't go in. In the vast majority of cases it did. A correctly used KwikPen delivers the full dose even if a small bleb remains at the surface, and our dedicated page on Mounjaro injection site lumps explains in detail why this happens and what you can expect as the tissue settles.
This is the decision that actually matters, and it is worth being honest: it is completely understandable to feel unsettled when something unexpected appears on your skin. Most lumps fall squarely into the normal category, but a few signs tell a different story.
A normal injection-site reaction: localised, roughly the size of a pea or small coin, mildly tender or itchy, no spreading redness, no heat radiating outward, and it shrinks noticeably within 24 hours. The NHS's guidance on tirzepatide side effects lists injection-site reactions (including nodules and erythema) as common, meaning they affect roughly one in ten users at some point.
Signs that warrant a call to your prescriber or GP the same day: the lump is still the same size or larger after 48 hours; it has become hot or noticeably red in a spreading ring rather than a contained dot; you have a fever; or there is any discharge. These could indicate a localised infection or, more rarely, a more significant allergic response. A persistent hard nodule that does not soften at all over two weeks (sometimes called a lipohypertrophy) can develop if the same tiny spot is used for injection after injection; it is not dangerous but it does impair absorption, so the site should be rested.
Signs requiring emergency care (call 999 or go to A&E): difficulty breathing, swelling of the face or throat, rapid heartbeat or collapse. A severe allergic reaction to tirzepatide is rare but possible, and these symptoms mean do not wait.
Prevention is largely about giving the tissue the best conditions to receive and absorb the dose. A few practical steps make a real difference.
First, rotate properly. The abdomen, outer thigh and upper arm are all approved sites, and moving between them (and between different spots within each area) means no single patch of tissue is repeatedly disrupted. Many people find it useful to think of each site as a grid and work systematically around it. More detail on the full process is in our guide to Mounjaro injections.
Second, let the pen warm up. Injecting a cold solution straight from the fridge can make the tissue react more sharply and the solution disperse more slowly. Taking the pen out ten to fifteen minutes before use (keeping the cap on, away from direct heat) is a small change that some people find helps noticeably. Never heat it artificially.
Third, inject slowly and hold for a count of ten after the click. Rushing the delivery is one of the most common causes of surface pooling. If you use a fresh needle each week (a new needle every injection is the clinical recommendation) you also avoid the tiny barb that forms on a reused needle tip, which increases tissue trauma.
Finally, clean the skin with an alcohol swab and let it dry completely before injecting. Damp skin can sting more sharply and alter how the tissue responds to the needle. Once the dose is in, release the skin naturally and avoid rubbing the site; gentle pressure with a clean tissue or cotton wool is fine if there is a small bleed, but massaging the area can push the solution into places it was not intended to go.
If lumps are happening every week, becoming more troublesome over time, or you are simply not confident your technique is right, that conversation belongs with your prescriber. It is not a small concern to brush off. Persistent injection-site problems can affect how much of the medicine reaches your system, which matters for how well treatment works over time.
At nume, a real clinician reviews every repeat order before it is approved, your prescriber can address technique questions, check whether a site reaction might point to something worth investigating, and adjust your plan if needed. If you have general questions between orders, our team is available seven days a week via the aftercare contact page.
For anyone weighing up whether a clinically supervised private route makes sense for their situation, our free consultation page explains what the assessment involves and what is included in the service. There is no obligation. Speak to our prescribers if you want a clearer picture of what is right for you.
For broader context on how Mounjaro works and what to expect from treatment, the Mounjaro overview covers the full picture. The NHS tirzepatide patient page is also worth bookmarking, it lists all known side effects clearly and tells you exactly when to seek further help.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.